Comparative Pharmacology
Head-to-head clinical analysis: PHARMASEAL SCRUB CARE versus PHISOHEX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PHARMASEAL SCRUB CARE versus PHISOHEX.
PHARMASEAL SCRUB CARE vs PHISOHEX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
PHARMASEAL SCRUB CARE is a combination topical antiseptic containing chlorhexidine gluconate and isopropyl alcohol. Chlorhexidine binds to negatively charged bacterial cell walls, disrupting membrane integrity and causing leakage of intracellular contents. Isopropyl alcohol denatures bacterial proteins and dissolves lipids, leading to rapid cell death.
Disrupts bacterial cell wall synthesis by binding to the bacterial ribosome and inhibiting protein synthesis; also has surfactant properties that disrupt bacterial cell membrane integrity.
No specific dosing; apply topical antiseptic as needed for surgical hand antisepsis; typical application: 5 mL per hand and forearm, scrub for 3-5 minutes, repeat as per institutional protocol.
Apply topically as a 3% emulsion to affected area, rinse thoroughly; typically used 1-2 times daily for up to 10 days.
None Documented
None Documented
Terminal elimination half-life is approximately 1.5–2 hours for chlorhexidine in plasma; prolonged to >24 hours in tissue compartments due to extensive protein binding and slow release.
Terminal elimination half-life approximately 6-7 hours in adults with normal renal function. Prolonged in renal impairment (up to 20 hours) due to reduced clearance of active metabolite (pentachlorophenol).
Primarily renal excretion of unchanged chlorhexidine (<1%) and its metabolites via glomerular filtration; biliary/fecal elimination accounts for >90% as degraded products.
Renal (biliary/fecal negligible). Up to 10% of dose excreted unchanged in urine; remainder as metabolites (glucuronide and sulfate conjugates).
Category C
Category C
Antiseptic/Disinfectant
Antiseptic